{"id":"tp-59843","type":"article-newspaper","title":"Palatin Targets First-Half 2027 Start for Lead Lipidated MC4R Peptide","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/59843","datePublished":"2026-11-17T21:00:17.000Z","dateModified":"2026-11-17T21:00:17.000Z","language":"en","abstract":"Fiscal 2027 first-quarter priorities included IND-enabling activities for the peptide and development of oral small-molecule candidates.","section":"Business","references":[]}